Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Nucleic Acids Research|November 30, 2011
Construction of repeat-free fluorescence in situ hybridization probesJoost F Swennenhuis, Brad Foulk, Frank A W Coumans, et al.
Methods (San Diego, Calif.)|July 13, 2013
Development of a method to isolate circulating tumor cells using mesenchymal-based captureRhonda L Bitting, Rengasamy Boominathan, Chandra Rao, et al.
Cancer|December 22, 2017
Identification of mechanisms of resistance to treatment with abiraterone acetate or enzalutamide in patients with castration-resistant prostate cancer (CRPC)Sumanta Kumar Pal, Jaymala Patel, Miaoling He, et al.
British Journal of Haematology|November 7, 2017
Enumeration and characterization of circulating multiple myeloma cells in patients with plasma cell disordersBrad Foulk, Mike Schaffer, Steve Gross, et al.
Blood Advances|March 10, 2020
A novel C2 domain binding CD33xCD3 bispecific antibody with potent T-cell redirection activity against acute myeloid leukemiaPriyanka Nair-Gupta, Michael Diem, Dara Reeves, et al.
Molecular Cancer Research : MCR|March 9, 2016
Development of a Novel c-MET-Based CTC Detection PlatformTian Zhang, Rengasamy Boominathan, Brad Foulk, et al.
Prostate Cancer and Prostatic Diseases|October 3, 2020
Blood-based gene expression signature associated with metastatic castrate-resistant prostate cancer patient response to abiraterone plus prednisone or enzalutamideNaomi B Haas, Michael J LaRiviere, Thomas H Buckingham, et al.
Leukemia|May 28, 2020
Deep immune profiling of patients treated with lenalidomide and dexamethasone with or without daratumumabTineke Casneuf, Homer C Adams, Niels W C J van de Donk, et al.
The New England Journal of Medicine|February 12, 2025
CAR+ T-Cell Lymphoma after Cilta-cel Therapy for Relapsed or Refractory MyelomaSimon J Harrison, Cyrille Touzeau, Nicolas Kint, et al.
Pageof 1